Country websites

Attention

The medical device and therapy related information on this website is aimed exclusively at healthcare professionals.

The product related information on the websites covers – unless explicitly stated otherwise – only CE marked products which are marketable in the European Union. Please be aware that not all products and services described on the following website are cleared or available for sale in all countries. Please check the relevant country web site for details.

By clicking the button “Accepted and Confirmed” you assure that you have taken note of this information.

Meet the new NxStage VersiHD

The confidence you need, the versatility patients love.

DISCLAIMER

Not all products and services are cleared or available for sale in all EU countries. Check your country web site for details. 

Introducing NxStage VersiHD and the versatility it offers

Versatile solutions make home hemodialysis more flexible and adaptable to patients’ needs. Together with their health care professional, patients can decide how often, how long, where and when to perform their treatment according to their prescription.

This helps improve treatment outcomes and gives patients more freedom to live their life their way.

Versatility, advancing the flexibility of home hemodialysis

Dialyze  More frequently

Dialyze 
More frequently

Patients who perform home hemodialysis may expand their treatment time to 4 - 7 days a week if required, in order to improve their treatment outcomes.

Frequent home dialysis is associated with improved survival.1-4

In general, more frequent and/or long duration hemodialysis may be associated with:

Less stress on the heart 5,6

blood_cells

Improved blood pressure control with less medication 6,7

Less restrictive diet 2,6

Potential for fewer dietary restrictions 8,9

quicker recovery time

Shorter recovery time after treatment10

Dialyze whenever

Dialyze
whenever

Nocturnal or short-daily hemodialysis

The nocturnal hemodialysis regimen tends to be closer to the physiology of the native kidneys than conventional hemodialysis.11 In addition, nocturnal hemodialysis has been associated with comparable survival values with a deceased donor kidney transplantation.12

Patients on short-daily hemodialysis may experience less toxin and fluid buildup, have shorter post-dialysis recovery time after treatment, and have more energy.10,13

Dialyze wherever

Dialyze
wherever

With the NxStage VersiHD, patients can dialyze almost in any area of their home.

PureFlow SL is designed to produce ultrapure dialysis water at a patient's home. A batch of dialysate can last up to 120 hours. It reduces the delivery, storage, and inventory management.

Pre-mixed dialysate bags are ideal for travelling.

The support you expect, the comfort patients seek

One cycler - two options for home and on the go

 

The features you want, the language patients speak

NxStage VersiHD features a smart touch screen interface that is designed to enhance ease of use.

Versatile home hemodialysis can make a difference

The fact that you can decide for yourself

The fact that you can decide for yourself, whether to dialyze in the morning or in the evening, or in the middle of the day — that was very important to me.

Bilel Ouerfelli

Click here to watch Bilel's story

Related content

1 Blagg CR, et al. Hemodial Int. 2006;10(4):371-4.

2 Kansal SK, et al. Perit Dial Int. 2019;39(1):25-34.

3 Weinhandl ED, et al. J Am Soc Nephrol. 2012;23(5):895-904.

4 Weinhandl ED, et al. Am J Kidney Dis. 2016;67(1):98-110

5 McCullough PA et al. Am J Kidney Dis 2016; 68(5);5–14

6 Susantitaphong P et al. Am J Kidney Dis 2012; 59(5):689–699

7 Kotanko P Hemodial Int 2015; 19(3):386-401

8 Watanabe Y et al. Hemodial Int 2014; 18(1):32-38

9 Tennankore KK et al. Nat Rev Nephrol 2012; 8(9):515-522

10 Jaber BL et al. Am J Kidney Dis 2010; 56(3):531-539

11 Roumeliotis A et al. Curr Vasc Pharmacol 2021; 19(1):21-33

12 Pauly RP et al. Nephrol Dial Transplant. 2009; 24:2915-2919

13 Finkelstein FO et al. Kidney Int. 2012 Sep; 82(5):561-9

14 Walker RC et al. Clin Outcomes Res 2017; 9:149-161

15 Cherukuri S et al. BMC Nephrol 2018; 19(1):262

16 Kessler M et al. Semin Dial. 2015; 28(5):474-489